Monitoring of the body's blood sugar is essential to the treatment of diabetes. But getting effective glucose readings has ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced compelling ...

Samsung has been working on a noninvasive solution for optical continuous glucose monitoring, that could one day come to ...

Shares of Trinity Biotech climbed after the company released what it called compelling results from a study of its next-generation continuous glucose monitoring system, a device used for diabetes ...

Trinity stock is trading higher on Tuesday after the company announced results from its pre-pivotal clinical trial for its ...

Trinity Biotech (TRIB) announced results from its latest pre-pivotal clinical trial for its next-generation continuous glucose monitoring ...

Time-in-range computed from virtual CGM data predicts retinopathy, neuropathy similarly to glycated hemoglobin data ...

Continuous Glucose Monitoring Systems (CGMS) have emerged as pivotal tools in the management of diabetes, offering real-time insights into glucose levels and revolutionizing patient care. The market ...

A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...

After a long wait, Galaxy Watch devices could finally receive the non-invasive blood glucose monitoring feature.

It is the only tubeless, fully disposable and automated insulin delivery system on the market. The continuous glucose monitor and the newest generation of the Omnipod pump are able to communicate ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...